Journal of Medicinal Chemistry p. 352 - 356 (1988)
Update date:2022-09-26
Topics: Chemical Synthesis Clinical Trials Regulatory Approval Pharmacokinetic Studies Toxicity and Safety Evaluation Biological Activity Testing Spectroscopic Characterization
Howson, W.
Kitteringham, J.
Mistry, J.
Mitchell, M. B.
Novelli, R.
et al.
6-<4-<3-<<2-Hydroxy-3-<4-<2-(cyclopropylmethoxy)ethyl>phenoxy>propyl>amino>propionamido>phenyl>-5-methyl-4,5-dihydro-3(2H)-pyridazinone (3) consists of a mixture of four stereoisomers, i.e., two racemates, as aconsequence of the two asymmetric centers con
View MoreContact:86-15588110016
Address:LINYI CITY,SHANDONG PROVINCE,CHINA
website:http://www.oceanchem-group.com
Contact:86-536-8596048
Address:9th floor,Building B future Plaza, No.88.Fenghuang Street,Weifang,Shandong,China
Contact:410-273-7300; 800-221-3953
Address:4609 Richlynn Dr., PO Box 369, Belcamp, MD, 21017-0369, USA
SHAANXI FUJIE PHARMACEUTICAL CO.,LTD
website:http://www.fujiepharm.com
Contact:+86-29-63650906
Address:Yuanqu Yi Road, Qinghe Food Industrial Park, Sanyuan County, Shaanxi Province, China
Contact:0311-13263231263
Address:jian hua street,Shijiazhuang City, China
Doi:10.1021/jo01074a027
(1960)Doi:10.1002/(SICI)1096-9063(199911)55:11<1116::AID-PS65>3.0.CO;2-Y
(1999)Doi:10.1016/j.tet.2008.10.109
(2009)Doi:10.1021/jo800950y
(2008)Doi:10.1021/ja710749q
(2008)Doi:10.1016/j.bmc.2015.08.005
(2015)
